Cantargia's CAN10 demonstrates positive activity in systemic sclerosis models in new data presented at ACR Convergence 2
(Nasdaq Stockholm: CANTA) today reported new preclinical data demonstrating positive effects of the...
United States Prnewswire Cantargia Heinrich Heine University Hiller Research Center Nasdaq Stockholm Systemic Sclerosis Related Disorders
Source: notimerica.com